Choices was there for my mother and myself when we went through breast cancer treatments. They provided counselling to my mother and advice to me. Every service is free. Any person affected by cancer can walk through their doors and receive open-armed assistance. Please help support me to raise funds for this excellent centre.
For those who live OS or can’t make it to the night you can donate by ‘buying a ticket’.
With love, Josie x.
Sara Douglass* died in 2011 of ovarian cancer. A great high fantasy writer for adults.
*click on link to read her words
My mother’s birthday is today. She would have been 68! She died 12 years ago, and I miss and love her to this day. This is my favourite photograph of her as an 18yr old doing her B.Sc. She refused to kill the rats after desexing them. She stole ‘Gertrude’ from the lab. The lab technicians were looking for it for a long time … the secret never got out.
2005, this is my mother and I a few months before she died (she was terminally ill with metastatic breast cancer).
2016, me in front of my mother’s mother’s Welsh dresser in Wales, UK.
2016, this is my great, great grandmother (I think the original owner of the Welsh dresser – quite a similarity with my beloved mother). The Welsh dresser is passed down through the daughter’s line. Though we don’t know where the gene for breast cancer was passed down (thinking through my maternal grandfather’s line – who we don’t know).
Click on the link to read a guide to understanding HER2+ breast cancer.
This guide was sourced from Dr Sara M. Tolaney’s webpage: retrieved 17.12.16 @ 5:50.
Dr. Tolaney is a medical oncologist at Dana-Farber Cancer Institute in Boston, Mass., where she focuses on developing new treatments for breast cancer. She is also a medical instructor at Harvard Medical School.
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from the University of California, San Francisco in 2002. She completed her residency in internal medicine at Johns Hopkins University and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute.
In 2009, I had triple positive breast cancer, meaning my type of cancer liked oestrogen, progesterone and the HER2 protein for breakfast. There are newer (and better) drug combinations on the market now. (See the wonky photograph).
I snapped this from, I believe, expatriate Australian Dr Shom Goel’s talk. If you’re based in the USA he’s a leading light in HER2 positive research at the Dana-Farber Cancer Institute.
T-DM1 is a targeted antibody-drug conjugate: Herceptin (trastuzumab) and emtansine (DM1). Herceptin binds to the receptor (on the cancer cells). Emtansine enters the cells and destroys them. This regimen is for women with metastatic breast cancer, and/or who’ve become resistant to Herceptin.
(From 2016 Clinical Oncology Society of Australia conference).